Ver­tex's non-opi­oid pain drug is ap­proved by FDA, bring­ing first of new class to mar­ket

The FDA ap­proved Ver­tex’s non-opi­oid drug for mod­er­ate to se­vere acute pain, bring­ing to mar­ket the first in a new class of al­ter­na­tives to painkillers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland